Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons.

Amita Gupta and colleagues discuss priorities in clinical research aimed at improving tuberculosis prevention and treatment in pregnant women, children, and people with HIV.

Bibliographic Details
Main Authors:	Amita Gupta, Michael D Hughes, Anthony J Garcia-Prats, Katherine McIntire, Anneke C Hesseling
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-08-01
Series:	PLoS Medicine
Online Access:	https://doi.org/10.1371/journal.pmed.1002882

id	doaj-345d97c792f64bf58393bd91f73dbf40
record_format	Article
spelling	doaj-345d97c792f64bf58393bd91f73dbf402021-06-03T04:30:58ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762019-08-01168e100288210.1371/journal.pmed.1002882Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons.Amita GuptaMichael D HughesAnthony J Garcia-PratsKatherine McIntireAnneke C HesselingAmita Gupta and colleagues discuss priorities in clinical research aimed at improving tuberculosis prevention and treatment in pregnant women, children, and people with HIV.https://doi.org/10.1371/journal.pmed.1002882
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Amita Gupta Michael D Hughes Anthony J Garcia-Prats Katherine McIntire Anneke C Hesseling
spellingShingle	Amita Gupta Michael D Hughes Anthony J Garcia-Prats Katherine McIntire Anneke C Hesseling Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons. PLoS Medicine
author_facet	Amita Gupta Michael D Hughes Anthony J Garcia-Prats Katherine McIntire Anneke C Hesseling
author_sort	Amita Gupta
title	Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons.
title_short	Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons.
title_full	Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons.
title_fullStr	Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons.
title_full_unstemmed	Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons.
title_sort	inclusion of key populations in clinical trials of new antituberculosis treatments: current barriers and recommendations for pregnant and lactating women, children, and hiv-infected persons.
publisher	Public Library of Science (PLoS)
series	PLoS Medicine
issn	1549-1277 1549-1676
publishDate	2019-08-01
description	Amita Gupta and colleagues discuss priorities in clinical research aimed at improving tuberculosis prevention and treatment in pregnant women, children, and people with HIV.
url	https://doi.org/10.1371/journal.pmed.1002882
work_keys_str_mv	AT amitagupta inclusionofkeypopulationsinclinicaltrialsofnewantituberculosistreatmentscurrentbarriersandrecommendationsforpregnantandlactatingwomenchildrenandhivinfectedpersons AT michaeldhughes inclusionofkeypopulationsinclinicaltrialsofnewantituberculosistreatmentscurrentbarriersandrecommendationsforpregnantandlactatingwomenchildrenandhivinfectedpersons AT anthonyjgarciaprats inclusionofkeypopulationsinclinicaltrialsofnewantituberculosistreatmentscurrentbarriersandrecommendationsforpregnantandlactatingwomenchildrenandhivinfectedpersons AT katherinemcintire inclusionofkeypopulationsinclinicaltrialsofnewantituberculosistreatmentscurrentbarriersandrecommendationsforpregnantandlactatingwomenchildrenandhivinfectedpersons AT annekechesseling inclusionofkeypopulationsinclinicaltrialsofnewantituberculosistreatmentscurrentbarriersandrecommendationsforpregnantandlactatingwomenchildrenandhivinfectedpersons
_version_	1721399942211174400

Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons.

Similar Items